From the Guest Editor


Abstract views: 68 / PDF downloads: 56

Authors

  • A. Feridun Işık

DOI:

https://doi.org/10.58600/eurjther972

Abstract

Lung cancer is still a detrimental problem for physicians and surgeons. Because of having no standard treatment and poor survival, enforces us to find new approaches for its eradication. However, we have a so long way to this purpose. Genetic and cell researches to find out its real etiology and pathway are developing. But today, patients with lung cancer are waiting for some treatment methods which ease and give hope themselves immediately. Surgery is the most hopeful way for radical solution of lung cancer. Recently, new anesthetic and surgical technics give us some important advantages that were very frightfully before.
In this issue, we aimed to emphasize the new researches, interventions and experimental studies about pulmonary carcinoma. All authors worked hard for this purpose. I appreciate all of them and the editor in chief Prof. Murat Sucu. I hope all articles will help us thinking and researching lung cancer in all ways.


Prof. A. Feridun Işık

Metrics

Metrics Loading ...

Downloads

Published

2018-02-01

How to Cite

Işık, A. F. (2018). From the Guest Editor. European Journal of Therapeutics, 24(S1), A-VIII. https://doi.org/10.58600/eurjther972

Issue

Section

Editorial